8:21 PM ET
Form 4
Insider Selling
Acadia Pharmaceuticals EVP, CFO Mark C. Schneyer Sells $69.3K of Stock
Mark C. Schneyer, EVP, CFO, sold 3,321 shares of Acadia Pharmaceuticals Inc at $20.88 a share, worth $69.3K in total on Oct 30, 2026. Shares held after the trade: 71,322 (-4.4%).
- Value
- $69.3K
- Shares
- 3,321
- Price
- $20.88
- Role
- EVP, CFO
- Holding change
- -4.4%
- Trade date
- Oct 30, 2026